Weiss Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90M Buy
+2,542,652
New +$75.1M 0.94% 22
2026
Q1
Sell
-425,565
Closed -$9.23M 759
2025
Q4
$9.23M Buy
425,565
+376,155
+761% +$7.42M 0.12% 141
2025
Q3
$748K Buy
+49,410
New +$612K 0.01% 394
2024
Q1
Sell
-12,671
Closed -$142K 474
2023
Q4
$142K Sell
12,671
-7,329
-37% -$71.4K 0.01% 314
2023
Q3
$234K Buy
+20,000
New +$226K 0.01% 132

Other funds holding ROIV

Weiss Asset Management's ROIV Position: Q2 2026 in Review

Weiss Asset Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 2,542,652 shares worth $90M. The stake represents 0.94% of the portfolio and ranks #22 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in ROIV as recently as Q4 2025.

Weiss Asset Management first reported a position in ROIV in Q3 2023 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Weiss Asset Management held 2,542,652 shares of Roivant Sciences worth $90M as of Q2 2026.
  • Roivant Sciences was a new Weiss Asset Management position in Q2 2026.
  • Roivant Sciences made up 0.94% of Weiss Asset Management's portfolio in Q2 2026, its #22 holding.
  • Weiss Asset Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.